US Approves Updated COVID Vaccines to Boost Protection This Fall

September 13, 2023: The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer-BioNTech to boost protection against the virus this fall.

The updated vaccines target the Omicron variant, now the dominant strain of COVID-19 in the US. The vaccines are expected to be available in the fall, just in time for the start of the cold and flu season.

The updated vaccines are similar to the original vaccines but have been modified to include genetic material from the Omicron variant. This is expected to make the vaccines more effective against Omicron and other variants.

The FDA has authorized the updated vaccines for people 18 and older. The vaccines are expected to be available in two doses, four weeks apart.

Here are some actional and practical takeaways from the article:

• The US has approved updated COVID-19 vaccines to boost protection against the virus this fall.
• The updated vaccines are designed to target the Omicron variant.
• The vaccines are expected to be available in the fall.
• The vaccines are authorized for people 18 and older.

Here are some additional details about the updated vaccines:

• The updated vaccines are similar to the original vaccines but have been modified to include genetic material from the Omicron variant.
• The FDA has authorized the updated vaccines for people 18 and older.
• The vaccines are expected to be available in two doses, four weeks apart.